Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis

European Respiratory Journal

Volumn 19, Issue 6, 2002, Pages 1119-1123

  Beeh, K M ^a   Beier, J ^a   Haas, I C ^a   Kornmann, O ^a   Micke, P ^a   Buhl, R ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Antioxidants; Glutathione; Induced sputum; Pulmonary fibrosis

Indexed keywords

ANTIOXIDANT; GLUTATHIONE; OXIDIZING AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE MARKER; FEMALE; HUMAN; INFLAMMATION; LOWER RESPIRATORY TRACT; LUNG FIBROSIS; LUNG FUNCTION; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SALIVA LEVEL; SPECTROPHOTOMETRY; SPUTUM LEVEL; SUPERNATANT; BLOOD; LUNG; METABOLISM; MIDDLE AGED; SALIVA; SPUTUM;

ADULT; AGED; FEMALE; GLUTATHIONE; HUMAN; LUNG; MALE; MIDDLE AGE; PULMONARY FIBROSIS; SALIVA; SPUTUM; HUMANS; MIDDLE AGED;

EID: 0035991339     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.02.00262402     Document Type: Article

References (25)

1. Interstitial lung diseases of unknown cause: Disorders characterized by chronic inflammation of the lower respiratory tract
2. Cytokines and cytokine networking in the pathogenesis of interstitial and fibrotic lung disorders
3. Idiopathic pulmonary fibrosis
4. New strategies for treatment of pulmonary fibrosis
5. Approaches to the treatment of pulmonary fibrosis
6. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis
7. Oxidants/antioxidants in idiopathic pulmonary fibrosis
8. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs
9. Extracellular antioxidant defenses
10. Oxidants and respiratory tract epithelial injury: Pathogenesis and strategies for therapeutic intervention
11. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis
12. Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals
13. Idiopathic pulmonary fibrosis diagnosis and treatment
14. Indices of airway inflammation in induced sputum: Reproducibility and validity of cell and fluid-phase measurements
15. Dithiothreitol, a new protective agent for SH groups
16. Systemic glutathione deficiency in symptom-free HIV seropositive individuals
17. Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol
18. Fractional analysis of sequential induced sputum samples during sputum induction: Evidence that different lung compartments are sampled at different time points
19. Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects
20. Determination of low-molecular-mass antioxidant concentrations in human respiratory tract lining fluids
21. Increased levels of glutathione in bronchoalveolar lavage fluid from patients with asthma
22. Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis
23. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis
24. Changes in alveolar-capillary barrier function in animals and humans
25. Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis